Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Heart rate variability to spot sleep apnea in people with high blood pressure

Official title: The Exploration of the Relationship Between Hypertension and Sleep Apnea Through Heart Rate Variability, and the Subsequent Investigation of Non-pharmacological and Pharmacological Treatments

Run by Kaohsiung Armed Forces General Hospital · NCT07603583 · Data updated 2026-11-12

We’re testing whether a noninvasive heart rate pattern can help detect obstructive sleep apnea in adults with hypertension.

More Hypertension trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorKaohsiung Armed Forces General Hospital
Academic / other
Locations1 site (Kaohsiung City, Kaohsiung)
StatusRecruiting
StartedApril 30, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMay 22, 2026
Trial IDNCT07603583 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18–65 with diagnosed hypertension (or resistant hypertension) and a STOP-Bang score ≥3 who can undergo Holter monitoring and overnight PSG.

Probably not a fit

Patients who do not have OSA or do not show HRV-OSA associations may not benefit from HRV-based screening.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study will recruit adults 18–65 with hypertension or resistant hypertension and a STOP-Bang score of 3 or higher. Participants will wear a 24-hour Holter monitor to measure heart rate variability and undergo overnight polysomnography to define OSA severity. Machine learning will be used to build models linking HRV features to apnea-hypopnea index and to predict OSA risk. A subset with diagnosed OSA will be followed after treatment to see how HRV and blood pressure respond. The goal is to identify a cost-effective approach for early detection, risk stratification, and management of OSA in hypertensive patients.

Why it matters

Potential benefit: If successful, this approach could enable earlier, noninvasive screening and better risk stratification for OSA in people with hypertension.

How similar studies have gone: Previous research suggests HRV can reflect autonomic changes related to sleep apnea, but applying ML to predict OSA severity in hypertensive patients is a newer approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 65 years
* Diagnosed hypertension or resistant hypertension
* STOP-Bang score ≥3 indicating high risk of obstructive sleep apnea
* Willing and able to provide informed consent

Exclusion Criteria:

* Refusal to undergo HRV monitoring or polysomnography
* Unstable medical condition that may interfere with study participation
* Inability to comply with study procedures

Where it's running

  • Kaohsiung Armed Forces General Hospital
    Kaohsiung City, Kaohsiung, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Yung Kuo Lee, PhD — Kaohsiung Armed Forces General Hospital
  • Study coordinator: Yung Kuo Lee, PhD
  • Email: abstyle0204@gmail.com
  • Phone: +886910977485

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.